Neurology
Found 25 results
Filters: Keyword is Female and Author is Gauthier, Susan A  [Clear All Filters]
2022
Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A et al..  2022.  Brain oxygen extraction fraction mapping in patients with multiple sclerosis.. J Cereb Blood Flow Metab. 42(2):338-348.
Li J, Huang W, Luo X, Wen Y, Cho J, Kovanlikaya I, Gauthier SA, Nguyen TD, Spincemaille P, Wang Y.  2022.  The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.. J Neuroimaging. 32(1):48-56.
Zinger N, Ponath G, Sweeney E, Nguyen TD, Lo CHung, Diaz I, Dimov A, Teng L, Zexter L, Comunale J et al..  2022.  Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions.. Neurol Neuroimmunol Neuroinflamm. 9(2)
2021
Tozlu C, Jamison K, Gu Z, Gauthier SA, Kuceyeski A.  2021.  Estimated connectivity networks outperform observed connectivity networks when classifying people with multiple sclerosis into disability groups.. Neuroimage Clin. 32:102827.
Sweeney EM, Nguyen TD, Kuceyeski A, Ryan SM, Zhang S, Zexter L, Wang Y, Gauthier SA.  2021.  Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging.. Neuroimage. 225:117451.
Gillen KM, Mubarak M, Park C, Ponath G, Zhang S, Dimov A, Levine-Ritterman M, Toro S, Huang W, Amici S et al..  2021.  QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.. Ann Clin Transl Neurol. 8(4):877-886.
2019
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
2018
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.  2018.  Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.. PLoS One. 13(8):e0201289.
Zhang S, Nguyen TD, Zhao Y, Gauthier SA, Wang Y, Gupta A.  2018.  Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions.. Neuroimage Clin. 18:143-148.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Kang Y, P Mozley D, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J et al..  2018.  Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.. J Neuroimaging. 28(5):496-505.
2017
Al-Kawaz M, Monohan E, Morris E, Perumal JS, Nealon N, Vartanian T, Gauthier SA.  2017.  Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans.. J Neuroimaging. 27(3):333-338.
Eskreis-Winkler S, Zhou D, Liu T, Gupta A, Gauthier SA, Wang Y, Spincemaille P.  2017.  On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.. Magn Reson Imaging. 35:154-159.
Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.  2017.  No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
2016
Nguyen TD, Deh K, Monohan E, Pandya S, Spincemaille P, Raj A, Wang Y, Gauthier SA.  2016.  Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.. Magn Reson Med. 76(2):456-65.
Chiang GC, Pinto S, Comunale JP, Gauthier SA.  2016.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.. J Neuroimaging. 26(3):289-95.
Zhang Y, Gauthier SA, Gupta A, Comunale J, Chiang GChia-Yi, Zhou D, Chen W, Giambrone AE, Zhu W, Wang Y.  2016.  Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).. J Magn Reson Imaging. 44(2):426-32.
Dayan M, Monohan E, Pandya S, Kuceyeski A, Nguyen TD, Raj A, Gauthier SA.  2016.  Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.. Hum Brain Mapp. 37(3):989-1004.
2015
Vargas WS, Monohan E, Pandya S, Raj A, Vartanian T, Nguyen TD, Rúa SMHurtado, Gauthier SA.  2015.  Measuring longitudinal myelin water fraction in new multiple sclerosis lesions.. Neuroimage Clin. 9:369-75.
Eskreis-Winkler S, Deh K, Gupta A, Liu T, Wisnieff C, Jin M, Gauthier SA, Wang Y, Spincemaille P.  2015.  Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging.. J Magn Reson Imaging. 42(1):224-9.
2014
Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y.  2014.  Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.. Radiology. 271(1):183-92.
2012
Kumar D, Nguyen TD, Gauthier SA, Raj A.  2012.  Bayesian algorithm using spatial priors for multiexponential T₂ relaxometry from multiecho spin echo MRI.. Magn Reson Med. 68(5):1536-43.
Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han X-M, Venkataraman A et al..  2012.  Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.. J Neurol Sci. 315(1-2):49-54.